Stimuli sensitive hydrogels for ophthalmic drug delivery: A review.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 3482766)

Published in Int J Pharm Investig on April 01, 2012

Authors

Swatantra Ks Kushwaha1, Prachi Saxena, Ak Rai

Author Affiliations

1: Department of Pharmacy, Pranveer Singh Institute of Technology, Kanpur, India.

Articles cited by this

Environment-sensitive hydrogels for drug delivery. Adv Drug Deliv Rev (2001) 5.06

Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm (2000) 4.52

Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery. Adv Drug Deliv Rev (1998) 1.80

Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Release (2001) 1.71

Carbopol/pluronic phase change solutions for ophthalmic drug delivery. J Control Release (2000) 1.50

In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate. Int J Pharm (2002) 1.28

Rheological evaluation of Gelrite in situ gels for ophthalmic use. Eur J Pharm Sci (1998) 1.27

Dynamic and equilibrium swelling behaviour of pH-sensitive hydrogels containing 2-hydroxyethyl methacrylate. Biomaterials (1990) 1.15

New biodegradable polymers for injectable drug delivery systems. J Control Release (1999) 1.07

4. Poly(NIPAAm) revisited - it has been 28 years since it was first proposed for use as a biomaterial: Original research article: Applications of thermally reversible polymers hydrogels in therapeutics and diagnostics, 1987; thermally reversible hydrogels: II. Delivery and selective removal of substances from aqueous solutions, 1986; a novel approach for preparation of pH-sensitive hydrogels for enteric drug delivery, 1991. J Control Release (2014) 1.07

Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur J Pharm Sci (1998) 1.07

Ocular evaluation of polyvinyl alcohol vehicle in rabbits. J Pharm Sci (1975) 1.00

Thermosensitive polymer-modified liposomes. Adv Drug Deliv Rev (2001) 1.00

Thermosetting gels with modulated gelation temperature for ophthalmic use: the rheological and gamma scintigraphic studies. J Control Release (2002) 1.00

Thermally reversible xyloglucan gels as vehicles for rectal drug delivery. J Control Release (1998) 0.99

Efficacy and tolerability of timolol maleate ophthalmic gel-forming solution versus timolol ophthalmic solution in adults with open-angle glaucoma or ocular hypertension: a six-month, double-masked, multicenter study. Clin Ther (2001) 0.94

Rheological studies of the gelation of deacetylated gellan gum (Gelrite) in physiological conditions. Eur J Pharm Sci (1999) 0.93

Controlled release of insulin from injectable biodegradable triblock copolymer. Pharm Res (2001) 0.89

Prolonged effect of liposomes encapsulating pilocarpine HCl in normal and glaucomatous rabbits. Int J Pharm (2000) 0.89

Preliminary study of prolonged acting drug delivery system for the treatment of glaucoma. Pharm Acta Helv (1981) 0.89

Cross-linked guar gum hydrogel discs for colon-specific delivery of ibuprofen: formulation and in vitro evaluation. Drug Deliv (2006) 0.86

Application of in vivo confocal microscopy to the objective evaluation of ocular irritation induced by surfactants. Int J Pharm (2000) 0.85

Limits on optimizing ocular drug delivery. J Pharm Sci (1991) 0.84

Long-term intraocular pressure-lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with Timoptic XE 0.5% in a 12-month study. Am J Ophthalmol (2000) 0.82

Use of fluorometry in assessing the efficacy of a cation-sensitive gel as an ophthalmic vehicle: comparison with scintigraphy. J Pharm Sci (1992) 0.80